SRIT India IPO: price band, dates, issue size, business model, financials and risks

SRIT India Limited, a Bengaluru-headquartered IT/ITeS (information technology and IT-enabled services) company focused on government and public-sector digital platforms and system integration, is set to launch a mainboard IPO in a price band of ₹123 to ₹130 per share. The issue opens on September 28, 2026 and closes on September 30, 2026, with listing scheduled for October 6, 2026. The IPO is sized at ₹218.40 crore and is entirely a fresh issue, with no offer for sale (OFS); accordingly, fresh issue proceeds are intended to accrue to the company (net of issue expenses).

What SRIT India does: platforms plus turnkey execution

SRIT India’s stated positioning is as a builder and operator of digital platforms and a system integrator that executes multi-year programmes, primarily for Government and public-sector customers. The company’s operating model combines proprietary software products with turnkey implementation, operations and maintenance (O&M), and managed services.

Across its portfolio, SRIT India operates in three core verticals:

Healthcare IT: The company works on hospital information systems (HIS) such as RHES/AbHIS, along with billing and revenue-cycle management offerings. In healthcare programmes, delivery can extend beyond initial deployment into O&M and support engagements.

Electronic governance (e-governance): SRIT India delivers citizen service and municipal workflow platforms, including e-District, PlanPermit, AgniPermit and e-Civic. This vertical is closely linked to public procurement processes and program roll-outs.

Telecommunications and broadband: The company undertakes network deployment and managed services and develops in-house products for OSS/BSS (operations support systems/business support systems), including R-Connect and RConverge.

In addition to these verticals, SRIT India has indicated expansion into AI-enabled solutions for governance, transport and healthcare use cases, and has referenced select overseas execution, including Qatar and the Middle East.

Track record and milestones cited in the offer documents

SRIT India traces its origins to 1999, when it was incorporated as Sobha Renaissance Information Technology Private Limited. The company later changed its name to SRIT India Private Limited in 2014 and converted into a public limited company in 2025, adopting the name SRIT India Limited.

The milestones cited by the company span a mix of software and systems-integration work across sectors. In the early 2000s, SRIT India references a multi-million-dollar contract for installation, testing and commissioning of a fixed wire and interconnect billing system (2003), followed by software re-engineering and a development partnership with a global inspection, certification and testing services provider (2004). In 2007, the company cites acquisition of a stake in Objective Systems Integrators Inc., described as a supplier of telecom OSS.

In healthcare, SRIT India cites delivery and commissioning of PACS/teleradiology/telemedicine software and related hardware for a private healthcare institution (2007). It also references engagement for an end-to-end health sector automation program spanning application and infrastructure upgrades, redesign and O&M across more than 2,200 healthcare facilities (2018). For international healthcare delivery, the company cites development of a RHES billing and revenue-cycle management solution for an institution operating in Europe and the Middle East (2019), and delivery and operation of HIS/ERP and BI & Analytics support for a government healthcare and social security corporation (2019).

For more recent execution, SRIT India cites establishing a branch office in Qatar (2023), development of an AI-enabled intelligent transport management system called SAFE KERALA (₹1,512.27 million) (2023), and the Qatar Health Information System (QHIS) unified insurance platform project (2023). In 2024, it cites a contract of about ₹2,500 million to supply, commission and maintain 4G LTE connectivity for around 15,000 ATMs/ADWMs of a public sector bank, and a forensic science laboratories computerisation project in Maharashtra (₹3,573.48 million) awarded by Telecommunications Consultants India Limited (TCIL).

The company also discloses 2026 term sheets: an arrangement and term sheet with Carnot Research Private Limited for a proposed investment (₹50 million for 10% stake), and a conditional binding term sheet with Blossom Multi Specialty Hospital for a proposed 50% acquisition at an indicative valuation of ₹2,800 million.

IPO structure, reservations, and proposed use of fresh issue proceeds

The SRIT India IPO is a 100% fresh issue of ₹218.40 crore with no OFS. This structure means there are no selling shareholders in the offer, and the proceeds from the fresh issue (net of issue expenses) are proposed to be deployed for company purposes.

As per the stated objects of the issue, SRIT India proposes to use the net proceeds towards:

Capital expenditure for modernization of existing products and redevelopment. The company’s stated context includes modernization and redevelopment of products, including healthcare platforms and additional modules.

Working capital requirements. SRIT India has indicated that execution can be working-capital-intensive, particularly for large, multi-year turnkey and managed-service projects.

Inorganic growth through unidentified acquisitions and other strategic initiatives and general corporate purposes. The object is stated, while specific allocation for this item is not specified in the provided slice.

In terms of category-wise allocation, the issue provides for reservation of 50% to Qualified Institutional Buyers (QIBs), 15% to Non-Institutional Investors (NIIs), and 35% to Retail Individual Investors (RIIs). The disclosed anchor framework states that up to 60% of the QIB portion may be allocated to anchor investors, and within the anchor portion, 33.33% is reserved for domestic mutual funds.

Because the issue opens on September 28, 2026, bid statistics prior to that date should be read only as “not yet opened for subscription” rather than as an indicator of demand.

Financial trajectory: revenue, profitability and balance sheet movement

SRIT India has reported growth in total revenue from FY2024 to FY2026, along with an increase in profit after tax (PAT) over the same period. The company’s total assets also expanded over these years, reflecting a larger reported balance sheet by FY2026.

The movement in profitability ratios is visible in the reported PAT margin across the three financial years in the offer context. Separately, the disclosed key performance indicators include an EBITDA margin (treated as a margin percentage) and a reported PAT margin figure.

For investors evaluating government-led and public-sector-heavy IT execution models, the financial narrative often centres on how project ramp-ups, delivery milestones, and O&M/managed services translate into reported revenue and PAT, alongside how working-capital requirements are funded and managed. SRIT India’s stated use of proceeds includes a material working-capital component, which ties directly to the company’s execution model as presented in the offer context.

Valuation and KPI context, plus grey market premium observations

The IPO context includes a standard KPI set that investors typically use for cross-company comparison and for understanding the offer’s valuation framework. SRIT India’s disclosed metrics include EPS, return on equity (ROE) and return on net worth (RoNW), an EBITDA margin percentage, a pre-IPO price-to-earnings (P/E) multiple, and a price-to-book multiple, along with a reported PAT margin and a reported debt-to-equity ratio.

These metrics provide context for comparing business models that mix platform development with implementation, integration and managed services. The relevance of each KPI can vary depending on whether a company’s revenues are more project-led or include longer-duration O&M and managed-service components attached to deployed platforms.

On grey market premium (GMP), the provided context includes two observations dated September 23, 2026, referenced to an issue price of ₹130, with GMP readings of ₹0 and ₹12. GMP is an unofficial market indicator and can change; it is not an exchange-reported measure of subscription.

Key risks highlighted and monitoring points for the offer period

The risk framing available in the provided context emphasises concentration across procurement channel, customer base and revenue vertical.

A large share of revenue is described as government tender-based, implying that fewer tenders, delayed procurement cycles, or lost bids can affect revenue and cash flows.

Customer concentration is highlighted through the stated contribution of the top-10 customers to revenue, implying that changes in a limited set of relationships can affect earnings outcomes.

Segment concentration is also indicated through the stated revenue contribution of the electronic governance vertical, implying that policy, budget or programme shifts in that segment could influence performance.

Monitoring points to track through the IPO period and subsequent disclosures, based on the stated business model and use-of-proceeds:

Whether the revenue mix changes across healthcare, electronic governance and telecommunications/broadband, given the stated segment concentration.

How working-capital deployment from the fresh issue aligns with execution requirements on turnkey and managed-service contracts.

Progress on modernization and redevelopment of existing products, including healthcare platforms and additional modules referenced in the offer context.

Any updates around inorganic growth and strategic initiatives, given the stated object of pursuing acquisitions and partnerships without a specified allocation in the provided slice.

Complete numeric snapshot

IPO terms and schedule

Key performance indicators and valuation

Category reservations and anchor allocation

Proposed use of fresh issue proceeds

Subscription status (23 Sep 2026)

Grey market premium (GMP) trend

GMP is an unofficial market indicator and can change; these are dated snapshot observations, not a listing forecast.